TrialEuropean urology oncology2025

A Phase 1b/2 Study of Talazoparib and Axitinib in Patients with Advanced Clear-cell Renal Cell Carcinoma.

Ritesh R Kotecha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.